Oral sequential therapy in the treatment of post-surgical epidural abscess and subdural empyema
Purpose The management of post-surgical subdural empyema and subdural abscess is not standardised. The objective was to analyse the efficacy and safety of oral sequential therapy (OST). Methods Retrospective observational study in a tertiary hospital in Vigo (Spain). We included adult patients with subdural abscess or epidural empyema with microbiological isolation. Clinical and demographic variables, isolated microorganisms and treatment regimens were included, as well as mortality and adverse effects during the follow-up period. Results Thirty patients were reviewed, two died due to causes other than infection. Six-month recurrence rate was 2/28 and all other patients (26/28) had clinical cure at the end of the treatment. The commonest isolated microorganisms were Gram-positive, especially Staphylococcus aureus. The most widely used oral antibiotic was trimethoprim–sulfamethoxazole (80%). No side effects related to oral treatment were observed. Conclusion After adequate source control, OST can be a safe practice in the management of post-surgical epidural abscess and subdural empyema..
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:50 |
|---|---|
| Enthalten in: |
Infection - 50(2022), 5 vom: 23. Apr., Seite 1385-1389 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Rubiñán, Pablo [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Themen: |
And safety |
|---|
| Anmerkungen: |
© The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2022 |
|---|
| doi: |
10.1007/s15010-022-01814-x |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC2079647865 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC2079647865 | ||
| 003 | DE-627 | ||
| 005 | 20230508165132.0 | ||
| 007 | tu | ||
| 008 | 221221s2022 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s15010-022-01814-x |2 doi | |
| 035 | |a (DE-627)OLC2079647865 | ||
| 035 | |a (DE-He213)s15010-022-01814-x-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 070 |a 610 |q VZ |
| 100 | 1 | |a Rubiñán, Pablo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Oral sequential therapy in the treatment of post-surgical epidural abscess and subdural empyema |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany 2022 | ||
| 520 | |a Purpose The management of post-surgical subdural empyema and subdural abscess is not standardised. The objective was to analyse the efficacy and safety of oral sequential therapy (OST). Methods Retrospective observational study in a tertiary hospital in Vigo (Spain). We included adult patients with subdural abscess or epidural empyema with microbiological isolation. Clinical and demographic variables, isolated microorganisms and treatment regimens were included, as well as mortality and adverse effects during the follow-up period. Results Thirty patients were reviewed, two died due to causes other than infection. Six-month recurrence rate was 2/28 and all other patients (26/28) had clinical cure at the end of the treatment. The commonest isolated microorganisms were Gram-positive, especially Staphylococcus aureus. The most widely used oral antibiotic was trimethoprim–sulfamethoxazole (80%). No side effects related to oral treatment were observed. Conclusion After adequate source control, OST can be a safe practice in the management of post-surgical epidural abscess and subdural empyema. | ||
| 650 | 4 | |a Intracranial epidural abscess | |
| 650 | 4 | |a Subdural empyema | |
| 650 | 4 | |a Surgical infection | |
| 650 | 4 | |a Oral sequential therapy | |
| 650 | 4 | |a And safety | |
| 700 | 1 | |a Pérez-Rodríguez, María Teresa |0 (orcid)0000-0003-2944-8610 |4 aut | |
| 700 | 1 | |a Domínguez, Antía |4 aut | |
| 700 | 1 | |a Sousa, Adrián |4 aut | |
| 700 | 1 | |a Lima, Olalla |4 aut | |
| 700 | 1 | |a Rubianes, Martín |4 aut | |
| 700 | 1 | |a Conde, Cesáreo |4 aut | |
| 700 | 1 | |a Álvarez-Fernández, Maximiliano |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Infection |d Springer Berlin Heidelberg, 1973 |g 50(2022), 5 vom: 23. Apr., Seite 1385-1389 |w (DE-627)129393010 |w (DE-600)185104-4 |w (DE-576)014777851 |x 0300-8126 |7 nnns |
| 773 | 1 | 8 | |g volume:50 |g year:2022 |g number:5 |g day:23 |g month:04 |g pages:1385-1389 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s15010-022-01814-x |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_267 | ||
| 912 | |a GBV_ILN_2018 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4305 | ||
| 951 | |a AR | ||
| 952 | |d 50 |j 2022 |e 5 |b 23 |c 04 |h 1385-1389 | ||